Tecartus cells dispersion for Uses, Dosage, Side Effects and more

Trade Name Tecartus cells dispersion for
Generic autologous anti-CD19-transduced CD3+ cells
Type
Therapeutic Class
Manufacturer Gilead Sciences Ltd
Available Country United Kingdom
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share